TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
FrostPharma AB
Closing information (x1000 EUR)
| Closing information | 2024/12 (consolidated) | 2023/12 | 2022/12 |
| Turnover |
25,863
|
16,493
|
12,523 |
| Financial expenses |
524
|
267
|
190 |
| Earnings before taxes |
668
|
1,262
|
2,544 |
| EBITDA |
2,182
|
1,649
|
2,795 |
| Total assets |
35,301
|
11,463
|
9,007 |
| Current assets |
15,580
|
10,746
|
8,263 |
| Current liabilities |
7,375
|
3,941
|
6,086 |
| Equity capital |
16,136
|
3,799
|
2,808 |
| - share capital |
5
|
5
|
5 |
| Employees (average) |
26
|
15
|
10 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 | 2022/12 |
| Solvency |
45.7%
|
33.1%
|
31.2% |
| Turnover per employee |
995
|
1,100
|
1,252 |
| Profit as a percentage of turnover |
2.6%
|
7.7%
|
20.3% |
| Return on assets (ROA) |
3.4%
|
13.3%
|
30.4% |
| Current ratio |
211.3%
|
272.7%
|
135.8% |
| Return on equity (ROE) |
4.1%
|
33.2%
|
90.6% |
| Change turnover | |||
| Change turnover % |
31%
|
76% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
50%
|
25% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.